Original Research
Published on 19 Dec 2019
JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
in NK and Innate Lymphoid Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2019.02972
- 9,032 views
- 14 citations
28 articles related to "Jak Inhibition"
Articles
Review
Published on 30 Aug 2022
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.955035
- 48,063 views
- 135 citations
Original Research
Published on 26 Jan 2023
JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1087986
- 11,673 views
- 16 citations
Editorial
Published on 28 Dec 2022
Editorial: JAK inhibition in autoimmune and inflammatory diseases
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.1120281
- 3,608 views
- 2 citations
Review
Published on 04 Mar 2025
JAK inhibition and axial spondyloarthritis: new steps on the path to understanding pathophysiology
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1488357
- 7,367 views
- 5 citations
Case Report
Published on 29 Jan 2024
Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1328005
- 5,731 views
- 8 citations
Original Research
Published on 14 Feb 2020
Senolytics (DQ) Mitigates Radiation Ulcers by Removing Senescent Cells
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01576
- 11,692 views
- 75 citations
Original Research
Published on 09 Oct 2023
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2023.1226760
- 2,776 views
- 3 citations
Case Report
Published on 07 Jan 2025
SOCS1 deficiency—crossroads of autoimmunity and autoinflammation—two case reports
in Pediatric Immunology
Frontiers in Pediatrics
doi 10.3389/fped.2024.1516017
- 2,785 views
- 1 citation
Review
Published on 13 Jul 2023
Epigenetics in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1206965
- 5,794 views
- 7 citations
Review
Published on 09 Oct 2019
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2019.02342
- 47,415 views
- 227 citations
Review
Published on 12 Feb 2026
Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2026.1668159
- 707 views
Case Report
Published on 02 Jul 2024
A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1399249
- 3,883 views
- 3 citations
Case Report
Published on 21 Feb 2023
Case report: JAK inhibition as promising treatment option of fatal RVCLS due to TREX1 mutation (pVAL235Glyfs*6)
in Neurogenetics
Frontiers in Neurology
doi 10.3389/fneur.2023.1118369
- 3,283 views
- 3 citations
Original Research
Published on 06 Sep 2023
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264496
- 7,407 views
- 6 citations
Case Report
Published on 04 Feb 2025
Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1515602
- 4,354 views